The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

Public health minister Jenni Minto said the jab would be available for babies born before 32 weeks to protect them over the ...

Higher risk babies can receive the nirsevimab vaccine from September – with the single jab replacing five monthly injections previously given to infants classed as being at high risk.

Premature babies can be given a new vaccine against a potentially life-threatening infection from later this year, the ...

Thousands of premature babies in the UK can now be protected against a common winter virus which can cause a dangerous lung ...

Residents in public residential aged care services aged 60 and over can now claim a free vaccine for Respiratory Syncytial ...

Premature babies in the UK can now be protected against RSV with a single, long-lasting injection available on the NHS for ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

【数据支撑】目前，Arexvy已获美国批准用于预防60岁及以上成年人中RSV相关疾病，同时也适用于50至59岁具有风险因素的成人。此次新申请主要针对年龄段在50岁以下但存在高风险因素的人群。美国FDA预计将在2026年上半年针对该申请做出决策，同时欧 ...

Blog - A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...